| 1 |
|
| 2 |
Wei Y, Qiu G, Lei B, et al. Oral delivery of propofol with methoxymethylphosphonic acid as the delivery vehicle [J]. J Med Chem, 2017, 60(20): 8580-8590. DOI: 10.1021/acs.jmedchem.7b01133.
|
| 3 |
Qin L, Ren L, Wan S, et al. Design, synthesis, and evaluation of novel 2, 6-disubstituted phenol derivatives as general anesthetics [J]. J Med Chem, 2017, 60(9): 3606-3617. DOI: 10.1021/acs.jmedchem.7b00254.
|
| 4 |
Teng Y, Ou MC, Wang X, et al. Pharmacokinetic and pharmacodynamic properties of ciprofol emulsion in Chinese subjects: a single center, open-label, single-arm dose-escalation phase 1 study [J]. Am J Transl Res, 2021, 13(12): 13791-13802.
|
| 5 |
Bian Y, Zhang H, Ma S, et al. Mass balance, pharmacokinetics and pharmacodynamics of intravenous HSK3486, a novel anaesthetic, administered to healthy subjects [J]. Br J Clin Pharmacol, 2021, 87(1): 93-105. DOI: 10.1111/bcp.14363.
|
| 6 |
Hu C, Ou X, Teng Y, et al. Sedation effects produced by a ciprofol initial infusion or bolus dose followed by continuous maintenance infusion in healthy subjects: a phase 1 trial [J]. Adv Ther, 2021, 38(11): 5484-5500. DOI: 10.1007/s12325-021-01914-4.
|
| 7 |
Liu Y, Yu X, Zhu D, et al. Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial [J]. Chin Med J (Engl), 2022, 135(9): 1043-1051. DOI: 10.1097/CM9.0000000000001912.
|
| 8 |
Liu Y, Peng Z, Liu S, et al. Efficacy and safety of ciprofol sedation in ICU patients undergoing mechanical ventilation: a multicenter, single-blind, randomized, non-inferiority trial [J]. Crit Care Med, 2023 June 2DOI: 10.1097/CCM.0000000000005920.
|
| 9 |
|
| 10 |
Li J, Wang X, Liu J, et al. Comparison of ciprofol (HSK3486) versus propofol for the induction of deep sedation during gastroscopy and colonoscopy procedures: A multi-centre, non-inferiority, randomized, controlled phase 3 clinical trial [J]. Basic Clin Pharmacol Toxicol, 2022, 131(2): 138-148. DOI: 10.1111/bcpt.13761.
|
| 11 |
|
| 12 |
Chen X, Guo P, Yang L, et al. Comparison and clinical value of ciprofol and oropofol in intraoperative adverse reactions, operation, resuscitation, and satisfaction of patients under painless gastroenteroscopy anesthesia [J]. Contrast Media Mol Imaging, 2022, 9541060. DOI: 10.1155/2022/9541060.
|
| 13 |
Zhong J, Zhang J, Fan Y, et al. Efficacy and safety of ciprofol for procedural sedation and anesthesia in non-operating room settings [J]. J Clin Anesth, 2023, 85: 111047. DOI: 10.1016/j.jclinane.2022.111047.
|
| 14 |
Luo Z, Tu H, Zhang X, et al. Efficacy and safety of HSK3486 for anesthesia/sedation in patients undergoing fiberoptic bronchoscopy: a multicenter, double-blind, propofol-controlled, randomized, phase 3 study [J]. CNS Drugs, 2022, 36(3): 301-313. DOI: 10.1007/s40263-021-00890-1.
|
| 15 |
Wu B, Zhu W, Wang Q, et al. Efficacy and safety of ciprofol-remifentanil versus propofol-remifentanil during fiberoptic bronchoscopy: a prospective, randomized, double-blind, non-inferiority trial [J]. Front Pharmacol, 2022, 13: 1091579.DOI: 10.3389/fphar.2022.1091579.
|
| 16 |
Chen BZ, Yin XY, Jiang LH, et al. The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study [J]. BMC Anesthesiol, 2022, 22(1): 245. DOI: 10.1186/s12871-022-01782-7.
|
| 17 |
|
| 18 |
Wang X, Wang X, Liu J, et al. Effects of ciprofol for the induction of general anesthesia in patients scheduled for elective surgery compared to propofol: a phase 3, multicenter, randomized, double-blind, comparative study [J]. Eur Rev Med Pharmacol Sci, 2022, 26(5): 1607-1617. DOI: 10.26355/eurrev_202203_28228.
|
| 19 |
Ding YY, Long YQ, Yang HT, et al. Efficacy and safety of ciprofol for general anaesthesia induction in elderly patients undergoing major noncardiac surgery: a randomised controlled pilot trial [J]. Eur J Anaesthesiol, 2022, 39(12): 960-963. DOI: 10.1097/EJA.0000000000001759.
|
| 20 |
Qin K, Qin WY, Ming SP, et al. Effect of ciprofol on induction and maintenance of general anesthesia in patients undergoing kidney transplantation [J]. Eur Rev Med Pharmacol Sci, 2022, 26(14): 5063-5071. DOI: 10.26355/eurrev_202207_29292.
|
| 21 |
Liang P, Dai M, Wang X, et al. Efficacy and safety of HSK3486 vs. propofol for the induction and maintenance of general anaesthesia: a multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial [J]. Eur J Anaesthesiol, 2023, 40(6): 399-406. DOI: 10.1097/EJA.0000000000001799.
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 |
|
| 26 |
Duan G, Lan H, Shan W, et al. Clinical effect of different doses of ciprofol for induction of general anesthesia in elderly patients: a randomized, controlled trial [J]. Pharmacol Res Perspect, 2023, 11(2): e01066. DOI: 10.1002/prp2.1066.
|
| 27 |
|
| 28 |
Liu SB, Yao X, Tao J, et al. Population total and unbound pharmacokinetics and pharmacodynamics of ciprofol and M4 in subjects with various renal functions [J]. Br J Clin Pharmacol, 2023, 89(3): 1139-1151. DOI: 10.1111/bcp.15561.
|
| 29 |
Yu L, Bischof E, Lu HH. Anesthesia with ciprofol in cardiac surgery with cardiopulmonary bypass: a case report [J]. World J Clin Cases, 2023, 11(1): 157-163. DOI: 10.12998/wjcc.v11.i1.157.
|